Common and specific effects of the two major forms of prolactin in the rat testis
Authors:
- 1 December 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 293 (6) , E1795-E1803
Abstract
Prolactin (PRL) has both stimulatory and inhibitory effects on testicular function, a finding we hypothesized may be related in some part to the form of the hormone present or administered. In the analysis of the pituitary secretion profiles of early pubescent vs. mature male rats, we found PRL released from early pubescent pituitaries had about twice the degree of phosphorylation. Treatment of mature males with either unmodified PRL (U-PRL) or phosphorylated PRL (via the molecular mimic S179D PRL) for a period of 4 wk (circulating level of ∼50 ng/ml) showed serum testosterone decreased by ∼35% only by treatment with the phospho-mimic S179D PRL. Given the specificity of this effect, it was initially surprising that both forms of PRL decreased testicular expression of 3β-hydroxysteroid dehydrogenase and steroidogenic acute regulatory protein. Both forms also increased expression of the luteinizing hormone receptor, but only S179D PRL increased the ratio of short to long PRL receptors. Endogenous PRL and luteinizing hormone levels were unchanged in all groups in this time frame, suggesting that effects on steroidogenic gene expression were directly on the testis. Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling analysis combined with staining for 3β-hydroxysteroid dehydrogenase and morphometric analysis showed that S179D PRL, but not U-PRL, increased apoptosis of Leydig cells, a finding supported by increased staining for Fas and Fas ligand in the testicular interstitium, providing an explanation for the specific effect on testosterone. S179D PRL, but not U-PRL, also increased apoptosis of primary spermatogonia, and U-PRL, but not S179D PRL, decreased apoptosis of elongating spermatids. Thus, in mature males, hyperprolactinemic levels of both forms of PRL have common effects on steroidogenic proteins, but specific effects on the apoptosis of Leydig and germ cells.Keywords
This publication has 65 references indexed in Scilit:
- S179D prolactin: Antagonistic agony!Molecular and Cellular Endocrinology, 2007
- A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormoneEndocrine-Related Cancer, 2006
- Pseudophosphorylated prolactin (S179D PRL) inhibits growth and promotes β-casein gene expression in the rat mammary glandCell and tissue research, 2002
- Biphasic Action of Prolactin in the Regulation of Murine Leydig Tumor Cell FunctionsEndocrinology, 2001
- Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assaysJournal of Molecular Endocrinology, 2000
- Fas and Fas Ligand Expression in Fetal and Adult Human Testis with Normal or Deranged SpermatogenesisThe Journal of Clinical Endocrinology & Metabolism, 2000
- Leydig Cell Apoptosis after the Administration of Ethane Dimethanesulfonate to the Adult Male Rat Is a Fas-Mediated ProcessEndocrinology, 1999
- Prolactin and MA-10 Leydig cell steroidogenesis: biphasic effects of prolactin and signal transductionEndocrinology, 1996
- Dose-dependent effects of human prolactin on the immature hypophysectomized rat testisEndocrinology, 1992
- Effects of Hyper- and Hypoprolactinernia on Gonadotropin Secretion, Rat Testicular Luteinizing Hormone/Human Chorionic Gonadotropin Receptors and Testosterone Production by Isolated Leydig CellsBiology of Reproduction, 1983